AU1513699A - Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same - Google Patents

Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same

Info

Publication number
AU1513699A
AU1513699A AU15136/99A AU1513699A AU1513699A AU 1513699 A AU1513699 A AU 1513699A AU 15136/99 A AU15136/99 A AU 15136/99A AU 1513699 A AU1513699 A AU 1513699A AU 1513699 A AU1513699 A AU 1513699A
Authority
AU
Australia
Prior art keywords
anincreased
producing
same
amorphous form
physically stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15136/99A
Inventor
Alexandr Borisovich Krasnokutsky
Nikolai Borisovich Leonidov
Svetlana Igorevna Uspenskaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1513699A publication Critical patent/AU1513699A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
AU15136/99A 1998-08-18 1998-08-18 Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same Abandoned AU1513699A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU1998/000269 WO2000010562A1 (en) 1998-08-18 1998-08-18 Physically stable and x-ray amorphous form of hydrochloride ranitidine having an increased anti-ulcer activity and method for producing the same

Publications (1)

Publication Number Publication Date
AU1513699A true AU1513699A (en) 2000-03-14

Family

ID=20130252

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15136/99A Abandoned AU1513699A (en) 1998-08-18 1998-08-18 Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same

Country Status (3)

Country Link
AU (1) AU1513699A (en)
RU (2) RU2385155C2 (en)
WO (1) WO2000010562A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
JPH09502698A (en) * 1993-03-05 1997-03-18 ヘクサル・アクチエンゲゼルシャフト Ranitidine hydrochloride crystalline cyclodextrin complex, process for its production and pharmaceutical composition containing the complex
DE9420259U1 (en) * 1994-12-17 1995-02-09 Roehm Gmbh Debittered ranitidine preparation

Also Published As

Publication number Publication date
WO2000010562A8 (en) 2001-03-15
RU2203048C2 (en) 2003-04-27
RU2385155C2 (en) 2010-03-27
WO2000010562A1 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
AU2466099A (en) Pharmaceutically active compounds and methods of use thereof
AU2480900A (en) Absorbent structure and method for production
AU4429500A (en) Electrode structure for iontophoresis devices and method of producing the same
AU2111199A (en) Benzenesulfonamides and benzamides as therapeutic agents
AU6746800A (en) Carbon-reinforced electrode and method of making same
SG115489A1 (en) Pharmaceutically active morpholinol
AU1101699A (en) Therapeutic pillow
EP1115396A4 (en) Pharmaceutically active compounds and methods of use thereof
AU7275000A (en) Absorbent body for an absorbent product and methods for producing an absorbent body
AU4829400A (en) Battery grid and method of making
AU6056500A (en) Process and composition for temporarily suppressing pain
AU5965399A (en) Pharmaceutically active composition
AU3938299A (en) Method of altering heartbeat
AU7416700A (en) Insulating shaped body and method for producing the same
EP1075184A4 (en) Compositions and methods for active vaccination
AU4981199A (en) Compositions and methods for modulating sexual activity
AU2662799A (en) Modified pharmacologically active agents and improved therapeutic methods employing same
AU3620300A (en) Catalyst structure and method of manufacture
AU4651900A (en) Methods and compositions for modulating ciliary neurotrophic factor activity
AU1513699A (en) Physically stable and x-ray amorphous form of hydrochloride ranitidine having anincreased antitumoral activity and method for producing the same
AU3702399A (en) Catalytically active structure
AU2420101A (en) Method and composition for the treatment of pain
AU8621398A (en) Method and device for capsulating active ingredients
AU1558700A (en) Combinations of active ingredients
AU6835500A (en) Tissue substitute and method for the production thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase